In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type 3 selected

Type

Guidance programme 9 selected

Guidance programme

Showing 1 to 4 of 4

TitleConsultationTypeConsultation end date
Bimekizumab for treating moderate to severe hidradenitis suppurativa [ID6134]Draft guidanceTechnology appraisal guidance
Fruquintinib for previously treated metastatic colorectal cancer ID6274Draft guidanceTechnology appraisal guidance
Elacestrant for treating oestrogen receptor-positive, HER2-negative advanced breast cancer with an ESR1 mutation after at least 1 endocrine treatment [ID6225]Draft guidanceTechnology appraisal guidance
Cabotegravir for preventing HIV-1 in adults and young people [ID6255]Draft guidanceTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All